Climate change is making seasonal allergies worse. Can your nose handle it? A March report says climate change is extending the pollen and mold allergy season and making it more intense. Mar 27, 2023 0 21
Study finds diverse differences in microbes in breast tumors from women of different races The breast tumors of Asian, Black and white women have very different cellular, microbial and genomic features that could potentially be used to personalize care or predict disease progression, according to new research by ... Mar 27, 2023 0 33
HIV genomes that hide in white blood cells offer new target to eliminate infections To develop treatments that may one day entirely rid the body of HIV infection, scientists have long sought to identify all of the places that the virus can hide its genetic code. Now, in a study using blood samples from men ... Mar 27, 2023 0 43
Average privately insured family spends $1,300 out of pocket for child's hospitalization, finds study After a child's hospital stay, many families covered by private insurance may experience sticker shock—on average spending $1,300 out of pocket—a new study in JAMA Pediatrics suggests. Mar 27, 2023 0 22
Routine preoperative medical consultations don't improve surgery outcomes, suggests large study A large observational study published in JAMA Internal Medicine suggests that most patients do not medically benefit from consultation with a medical specialist before their surgery. Mar 27, 2023 0 44
Comprehensive testing technique for post-translational modification drug interactions A research team of 37 scientists, led by the Technical University of Munich, has developed a method to interrogate drug-induced post-translational modifications (PTMs) in a time and dose-dependent way. Mar 27, 2023 report 0 28
Atezolizumab as a primer for chemoradiation is promising for women with locally advanced cervical cancer Locally advanced cervical cancer remains an area of high therapeutic need, with recent trials failing to demonstrate evidence of benefit from adjuvant chemotherapy or immune checkpoint blockade administered concurrent with ... Mar 27, 2023 0 8
Clinical study: Treatment improves outcomes for women with locally advanced vulvar cancer Results from the NRG Oncology Phase II NRG-GOG-0279 clinical study indicate that women with locally advanced squamous cell carcinoma of the vulva who received gemcitabine concurrently with cisplatin and intensity-modulated ... Mar 27, 2023 0 3
Study identifies two promising molecular targets for drug development in recurrent and metastatic cervical cancer NRG Oncology GOG-0240 is the phase 3 randomized trial that demonstrated that the incorporation of bevacizumab with chemotherapy resulted in a statistically significant and clinically meaningful survival benefit for women ... Mar 27, 2023 0 2
Study: Socially vulnerable carry disproportionate COVID burden due to lower likelihood of vaccination The burden of the pandemic has disproportionately affected socially vulnerable populations. One of the first studies to look at the intersection of social vulnerability with COVID-19 vaccine utilization and effectiveness ... Mar 27, 2023 0 13
